Jefferies Downgrades Genzyme To Hold (GENZ)
By Benzinga Staff
February 17, 2011 8:27 AM
February 17, 2011 8:27 AM
Jefferies downgraded Genzyme (NASDAQ: GENZ) from Buy to Hold in a research report published today.
In the report, Jefferies states, "Upon announcement of the definite agreement whereby SNY is to acquire GENZ for $74/sh in cash + CVRs worth up to $14/sh, we are downgrading GENZ shares to Hold from Buy."
Shares of Genzyme closed Thursday at $75.10, up 1.07% from Wednesday's market close.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
